Oppenländer Rechtsanwälte boasts expertise in competition and pharmaceutical advertising law and advises on the the entire value chain of a medical device – from development to distribution. Other mainstays are the support in procurement, pharmaceutical advertising and pharmaceutical law matters; the team is renowned for the expertise in the pharmacy sector, Timo Kieser is a key contact here. Kieser jointly heads the practice with Christina Koppe-Zagouras, who impresses with specialist know-how at the interface between IP and pharmaceutical advertising law, and Katharina Köbler, who covers regulatory and contract-related matters.
Legal 500 Editorial commentary
- Profile
Testimonials
Collated independently by Legal 500 research team.
'Katharina Köbler has excellent specialist knowledge. She responds very quickly to inquiries and provides very practical and clearly understandable solutions that are perfectly adapted to the circumstances of the case.'
'Katharina Köbler is always easy to contact and always responds within the promised time frame. The advice was always very good, Katharina Köbler is very competent and friendly.'
'The firm is well-known and proven in the healthcare industry.'
'Katharina Köbler quickly understands legal matters that are not in focus and offers reliable and fast advice.'
Key clients
- Accord Healthcare GmbH
- Accord Healthcare Ltd.
- Andreas Hettich GmbH & Co. KG
- anmed GmbH
- Biologische Heilmittel Heel GmbH
- Cadewa UG
- Cipla Europe NV; Cipla Ltd.
- Dr. Falk Pharma GmbH
- Dr. Güldener Firmengruppe
- GlaxoSmithKline Consumer Healtcare GmbH & Co. KG (HALEON)
Work highlights
- Defense of Accord Healthcare GmbH against an attack by Takeda under competition law and medicinal product advertising law against numerous professional advertising materials for a cancer therapeutic before the Hamburg Regional Court.
- Advising Cipla Europe NV on issues regarding the tendering of pharmaceutical discount contracts for all German health insurance companies.
- Representation of GlaxoSmithKline Consumer Healtcare GmbH & Co. KG (HALEON) in disputes with competitors, including with regard to OTC preparations.